Skip to main content

GOLDMAN SACHS GROUP INC

Position in SLDB — Solid Biosciences Inc.

CIK 886982 NEW YORK, NY

Position in SLDB

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$16,013,140
+$9,277,289 QoQ
Shares Held
1,602,917
+71.3% QoQ
Ownership
1.49%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#20
of 155 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SLDB Over Time

Shares Held

Position Value (USD)

Derivatives in SLDB

reported options exposure · as of Jun 30, 2026
CallValue
$999,000
CallShares
100,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,040,376,854 across 359 Biotechnology names. SLDB ranks #131 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SLDB

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $16,013,140 1,602,917
2026-06-30 $999,000 100,000
2026-03-31 $6,735,851 935,535
2025-12-31 $5,675,565 1,006,306
2025-09-30 $4,174,788 676,627
2025-06-30 $1,859,146 381,755
2025-03-31 $666,506 180,137
2024-12-31 $544,908 136,227
2024-09-30 $763,897 109,598
2024-06-30 $274,319 48,381
2024-03-31 $2,713,923 203,748
2022-09-30 $65,408 140,062
2022-06-30 $235,941 383,022
2022-03-31 $422,891 352,410
2021-12-31 $848,172 484,670
2021-09-30 $765,863 320,445
2021-06-30 $202,723 55,389
2021-03-31 $366,306 66,240
2020-12-31 $392,621 51,797
2020-09-30 $114,838 56,571
2020-06-30 $157,700 53,823
2020-03-31 $134,944 56,462